Physicochemical Profiling of Baicalin Along with the Development and Characterization of Cyclodextrin Inclusion Complexes

Géza Jakab, Dóra Bogdán, Károly Mazák, Ruth Deme, Zoltán Mucsi, I. Mándity, B. Noszál, Nikolett Kállai-Szabó, I. Antal

Research output: Contribution to journalArticle

Abstract

Baicalin is a flavone glycoside extracted from Scutellaria baicalensis, a traditional Chinese herbal medicine. Numerous pharmacological effects of baicalin were reported (e.g. antioxidant, anxiolytic); nevertheless, the most important physicochemical properties influencing the pharmacokinetic behaviour and the concomitant oral bioavailability have not yet been described in a comprehensive study. The aim of this project was to characterize the acid-base, lipophilicity, biorelevant solubility and permeability properties of the drug substance and providing scientific data to support the dosage form design. Another important objective was the comparative evaluation of six various baicalin-cyclodextrin (CD) inclusion complexes along with the creation of a suitable Drug Delivery System (DDS) for this BCS IV drug. Biorelevant profiling was carried out by NMR-pH titrations, saturation shake-flask and distribution coefficients (logP) measurements, while CD inclusion studies were fulfilled by experimental methods (phase solubility, 1H/13C NMR, 2D ROESY) and computational approaches. Due to low aqueous solubility (67.03 ± 1.60 μg/ml) and low permeability (Papp = 0.037 × 10-6 cm/s), baicalin is classified as BCS IV. The γ-CD complexation significantly increased the solubility of baicalin (~ 5 times). The most promoted chemical shift change occurred in baicalin-γ-CD complex. Computational studies showed disparate binding pattern for baicalin in case of β- and γ-CD; furthermore, the calculated complexation energy was - 162.4 kJ mol-1 for β-CD, while it was significantly stronger for γ-CD (- 181.5 kJ mol-1). The physicochemical and structural information of baicalin and its CD complexes introduced herein can create molecular basis for a promising DDS with enhanced bioavailability containing a bioactive phytopharmacon.

Original languageEnglish
Number of pages1
JournalAAPS PharmSciTech
Volume20
Issue number8
DOIs
Publication statusPublished - Sep 16 2019

Fingerprint

Cyclodextrins
Solubility
flavone
Drug Delivery Systems
Biological Availability
Permeability
Scutellaria baicalensis
baicalin
Herbal Medicine
Anti-Anxiety Agents
Dosage Forms
Glycosides
Pharmaceutical Preparations
Pharmacokinetics
Antioxidants
Pharmacology
Acids

Keywords

  • baicalin
  • computational modelling
  • cyclodextrins
  • physicochemical analysis
  • solubility enhancement

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Physicochemical Profiling of Baicalin Along with the Development and Characterization of Cyclodextrin Inclusion Complexes. / Jakab, Géza; Bogdán, Dóra; Mazák, Károly; Deme, Ruth; Mucsi, Zoltán; Mándity, I.; Noszál, B.; Kállai-Szabó, Nikolett; Antal, I.

In: AAPS PharmSciTech, Vol. 20, No. 8, 16.09.2019.

Research output: Contribution to journalArticle

Jakab, Géza ; Bogdán, Dóra ; Mazák, Károly ; Deme, Ruth ; Mucsi, Zoltán ; Mándity, I. ; Noszál, B. ; Kállai-Szabó, Nikolett ; Antal, I. / Physicochemical Profiling of Baicalin Along with the Development and Characterization of Cyclodextrin Inclusion Complexes. In: AAPS PharmSciTech. 2019 ; Vol. 20, No. 8.
@article{068a75443ec9417a9ffd9491add5947a,
title = "Physicochemical Profiling of Baicalin Along with the Development and Characterization of Cyclodextrin Inclusion Complexes",
abstract = "Baicalin is a flavone glycoside extracted from Scutellaria baicalensis, a traditional Chinese herbal medicine. Numerous pharmacological effects of baicalin were reported (e.g. antioxidant, anxiolytic); nevertheless, the most important physicochemical properties influencing the pharmacokinetic behaviour and the concomitant oral bioavailability have not yet been described in a comprehensive study. The aim of this project was to characterize the acid-base, lipophilicity, biorelevant solubility and permeability properties of the drug substance and providing scientific data to support the dosage form design. Another important objective was the comparative evaluation of six various baicalin-cyclodextrin (CD) inclusion complexes along with the creation of a suitable Drug Delivery System (DDS) for this BCS IV drug. Biorelevant profiling was carried out by NMR-pH titrations, saturation shake-flask and distribution coefficients (logP) measurements, while CD inclusion studies were fulfilled by experimental methods (phase solubility, 1H/13C NMR, 2D ROESY) and computational approaches. Due to low aqueous solubility (67.03 ± 1.60 μg/ml) and low permeability (Papp = 0.037 × 10-6 cm/s), baicalin is classified as BCS IV. The γ-CD complexation significantly increased the solubility of baicalin (~ 5 times). The most promoted chemical shift change occurred in baicalin-γ-CD complex. Computational studies showed disparate binding pattern for baicalin in case of β- and γ-CD; furthermore, the calculated complexation energy was - 162.4 kJ mol-1 for β-CD, while it was significantly stronger for γ-CD (- 181.5 kJ mol-1). The physicochemical and structural information of baicalin and its CD complexes introduced herein can create molecular basis for a promising DDS with enhanced bioavailability containing a bioactive phytopharmacon.",
keywords = "baicalin, computational modelling, cyclodextrins, physicochemical analysis, solubility enhancement",
author = "G{\'e}za Jakab and D{\'o}ra Bogd{\'a}n and K{\'a}roly Maz{\'a}k and Ruth Deme and Zolt{\'a}n Mucsi and I. M{\'a}ndity and B. Nosz{\'a}l and Nikolett K{\'a}llai-Szab{\'o} and I. Antal",
year = "2019",
month = "9",
day = "16",
doi = "10.1208/s12249-019-1525-6",
language = "English",
volume = "20",
journal = "AAPS PharmSciTech",
issn = "1530-9932",
publisher = "American Association of Pharmaceutical Scientists",
number = "8",

}

TY - JOUR

T1 - Physicochemical Profiling of Baicalin Along with the Development and Characterization of Cyclodextrin Inclusion Complexes

AU - Jakab, Géza

AU - Bogdán, Dóra

AU - Mazák, Károly

AU - Deme, Ruth

AU - Mucsi, Zoltán

AU - Mándity, I.

AU - Noszál, B.

AU - Kállai-Szabó, Nikolett

AU - Antal, I.

PY - 2019/9/16

Y1 - 2019/9/16

N2 - Baicalin is a flavone glycoside extracted from Scutellaria baicalensis, a traditional Chinese herbal medicine. Numerous pharmacological effects of baicalin were reported (e.g. antioxidant, anxiolytic); nevertheless, the most important physicochemical properties influencing the pharmacokinetic behaviour and the concomitant oral bioavailability have not yet been described in a comprehensive study. The aim of this project was to characterize the acid-base, lipophilicity, biorelevant solubility and permeability properties of the drug substance and providing scientific data to support the dosage form design. Another important objective was the comparative evaluation of six various baicalin-cyclodextrin (CD) inclusion complexes along with the creation of a suitable Drug Delivery System (DDS) for this BCS IV drug. Biorelevant profiling was carried out by NMR-pH titrations, saturation shake-flask and distribution coefficients (logP) measurements, while CD inclusion studies were fulfilled by experimental methods (phase solubility, 1H/13C NMR, 2D ROESY) and computational approaches. Due to low aqueous solubility (67.03 ± 1.60 μg/ml) and low permeability (Papp = 0.037 × 10-6 cm/s), baicalin is classified as BCS IV. The γ-CD complexation significantly increased the solubility of baicalin (~ 5 times). The most promoted chemical shift change occurred in baicalin-γ-CD complex. Computational studies showed disparate binding pattern for baicalin in case of β- and γ-CD; furthermore, the calculated complexation energy was - 162.4 kJ mol-1 for β-CD, while it was significantly stronger for γ-CD (- 181.5 kJ mol-1). The physicochemical and structural information of baicalin and its CD complexes introduced herein can create molecular basis for a promising DDS with enhanced bioavailability containing a bioactive phytopharmacon.

AB - Baicalin is a flavone glycoside extracted from Scutellaria baicalensis, a traditional Chinese herbal medicine. Numerous pharmacological effects of baicalin were reported (e.g. antioxidant, anxiolytic); nevertheless, the most important physicochemical properties influencing the pharmacokinetic behaviour and the concomitant oral bioavailability have not yet been described in a comprehensive study. The aim of this project was to characterize the acid-base, lipophilicity, biorelevant solubility and permeability properties of the drug substance and providing scientific data to support the dosage form design. Another important objective was the comparative evaluation of six various baicalin-cyclodextrin (CD) inclusion complexes along with the creation of a suitable Drug Delivery System (DDS) for this BCS IV drug. Biorelevant profiling was carried out by NMR-pH titrations, saturation shake-flask and distribution coefficients (logP) measurements, while CD inclusion studies were fulfilled by experimental methods (phase solubility, 1H/13C NMR, 2D ROESY) and computational approaches. Due to low aqueous solubility (67.03 ± 1.60 μg/ml) and low permeability (Papp = 0.037 × 10-6 cm/s), baicalin is classified as BCS IV. The γ-CD complexation significantly increased the solubility of baicalin (~ 5 times). The most promoted chemical shift change occurred in baicalin-γ-CD complex. Computational studies showed disparate binding pattern for baicalin in case of β- and γ-CD; furthermore, the calculated complexation energy was - 162.4 kJ mol-1 for β-CD, while it was significantly stronger for γ-CD (- 181.5 kJ mol-1). The physicochemical and structural information of baicalin and its CD complexes introduced herein can create molecular basis for a promising DDS with enhanced bioavailability containing a bioactive phytopharmacon.

KW - baicalin

KW - computational modelling

KW - cyclodextrins

KW - physicochemical analysis

KW - solubility enhancement

UR - http://www.scopus.com/inward/record.url?scp=85072292894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072292894&partnerID=8YFLogxK

U2 - 10.1208/s12249-019-1525-6

DO - 10.1208/s12249-019-1525-6

M3 - Article

C2 - 31529175

AN - SCOPUS:85072292894

VL - 20

JO - AAPS PharmSciTech

JF - AAPS PharmSciTech

SN - 1530-9932

IS - 8

ER -